TEM,PFE Stock Price and Quote

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -3.59
Percentage change -7.78	%

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK ARKG IBB JTEK ROBT IPO THNQ VTI BBMC ONEQ

Index	-	P/E	-	EPS (ttm)	-4.75	Insider Own	54.70%	Shs Outstand	157.08M	Perf Week	-10.98%
Market Cap	7.37B	Forward P/E	216.50	EPS next Y	0.20	Insider Trans	-10.25%	Shs Float	78.38M	Perf Month	-12.85%
Income	-746.33M	PEG	-	EPS next Q	-0.25	Inst Own	24.53%	Short Float	21.95%	Perf Quarter	24.32%
Sales	693.40M	P/S	10.63	EPS this Y	62.75%	Inst Trans	5.77%	Short Ratio	1.27	Perf Half Y	-16.92%
Book/sh	0.35	P/B	122.53	EPS next Y	133.41%	ROA	-94.73%	Short Interest	17.21M	Perf Year	-
Cash/sh	2.59	P/C	16.44	EPS next 5Y	-	ROE	-	52W Range	22.89 - 91.45	Perf YTD	26.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-32.48%	ROI	-144.09%	52W High	-53.44%	Beta	-
Dividend TTM	-	Quick Ratio	2.16	Sales past 5Y	39.44%	Gross Margin	53.20%	52W Low	86.02%	ATR (14)	5.54
Dividend Ex-Date	Jul 18, 2006	Current Ratio	2.29	EPS Y/Y TTM	-195.58%	Oper. Margin	-99.28%	RSI (14)	39.06	Volatility	9.65% 9.89%
Employees	2400	Debt/Eq	8.31	Sales Y/Y TTM	30.38%	Profit Margin	-107.63%	Recom	2.15	Target Price	63.70
Option/Short	Yes / Yes	LT Debt/Eq	8.19	EPS Q/Q	81.63%	Payout	-	Rel Volume	0.85	Prev Close	46.17
Sales Surprise	-1.20%	EPS Surprise	-15.16%	Sales Q/Q	35.85%	Earnings	Feb 24 AMC	Avg Volume	13.55M	Price	42.58
SMA20	-12.51%	SMA50	-25.97%	SMA200	-13.20%	Trades		Volume	11,529,419	Change	-7.78%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Show Previous Ratings

Today 07:15PM	Tempus AI, Inc. (TEM): Among Stocks That Will Profit From AI (Insider Monkey) -7.78%
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 08:30AM	Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting (Business Wire)
07:15AM	Loading…
07:15AM	4 Healthcare Stocks With Massive Gains-and More to Come (MarketBeat)
Mar-27-25 03:55AM	Why Tempus AI Inc. (TEM) Crashed On Wednesday? (InsiderMonkey)
Mar-26-25 10:58AM	Is Tempus AI Inc. (NASDAQ:TEM) the Best AI Stock to Invest in According to Reddit? (InsiderMonkey) -9.08%
08:30AM	Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-25-25 08:45AM	AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs (GlobeNewswire)
08:30AM	Tempus AI's Valuation Bakes In Strong Growth - A Hold For Now (SeekingAlpha)
Mar-24-25 11:49PM	Tempus AI Inc. (TEM)Among Cathie Wood's Top AI Stock Picks in 2025 (InsiderMonkey) +14.90%
Mar-22-25 03:15AM	Why Tempus AI (TEM) Went Up On Friday? (InsiderMonkey)
Mar-19-25 02:13PM	Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight (Zacks) +5.01%
Mar-17-25 09:08AM	Tempus AI (TEM) Expands Precision Medicine Capabilities with Deep 6 AI Acquisition (Insider Monkey) +5.72%
10:17PM	Loading…
Mar-16-25 10:17PM	Tempus AI, Inc. (TEM): Among Top Insider Sales Last Month (Insider Monkey)
Mar-14-25 10:10AM	Is Tempus AI, Inc. (TEM) the Best Performing Growth Stock in 2025? (Insider Monkey) +11.87%
Mar-11-25 05:15PM	Tempus Announces Acquisition of Deep 6 AI (Business Wire)
10:09AM	Why Tempus AI (TEM) Shares Are Soaring: The Cathie Wood Effect (Insider Monkey)
Mar-07-25 10:00PM	Why Does Nancy Pelosi Like Tempus AI (TEM) Stock So Much? (Benzinga) -8.00%
09:10PM	Tempus AI, Inc. (TEM): Among The Stocks With At Least $10 Million In Insider Sales Recently (Insider Monkey)
Mar-05-25 11:20AM	JPMorgan Downgrades Tempus AI, Inc. (TEM) to Neutral Despite Positive 2025 Guidance (Insider Monkey)
Mar-03-25 03:33PM	Analyst says AI stock picked by Cathie Wood will surge (TheStreet) -9.34%
Mar-02-25 06:20AM	Street Calls of the Week (Investing.com)
Feb-27-25 06:26PM	Tempus AI, Inc. (TEM) Reaffirmed as Buy with Strong Growth Outlook (Insider Monkey) -11.18%
12:04PM	SCOPE 2025: investors share optimism and obstacles for AI in clinical operations (Pharmaceutical Technology)
Feb-26-25 05:47PM	Cathie Wood buys $27 million of tumbling AI stock (TheStreet) +5.35%
12:27PM	Why Tempus AI, Inc. (TEM) Went Down on Tuesday (Insider Monkey)
11:10AM	Ark Invest Buys the Dip as Cathie Wood Snaps Up Tempus AI Shares (GuruFocus.com)
10:00AM	Tempus AI Stock Has Soared 108% Already in 2025; Is It a Buy Now? (Motley Fool)
04:22PM	Loading…
Feb-25-25 04:22PM	Tempus AI Reverses 192% Run. Why At Least One Analyst Remains A Believer. (Investor's Business Daily) -15.05%
03:38PM	Tempus AI, Inc. (TEM) Reports Strong Q4 Growth, Fueled by AI-Driven Diagnostics (Insider Monkey)
03:32PM	Stock Market Today: Dow Jones Improves; Tesla Skids Again While Techs Keep Tumbling (Live Coverage) (Investor's Business Daily)
11:07AM	Stock Market Today: Dow Jones, S&P 500 Fall; Hims & Hers Tanks, Bitcoin Falls (Live Coverage) (Investor's Business Daily)
11:05AM	Tempus AI Costs, Outlook Send Stock Sharply Lower (Investopedia)
10:31AM	Q4 2024 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents)
10:05AM	JP Morgan cuts Tempus AI rating to neutral after stocks sharp rally (Investing.com)
09:29AM	Tempus AI, Inc. (TEM) and Menarini Group Leverage AI to Advance Breast Cancer Care (Insider Monkey)
02:03AM	Tempus AI Inc (TEM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves (GuruFocus.com)
Feb-24-25 05:36PM	Tempus Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
05:23PM	Tempus AI Stock Drops After Company Posts Q4 Results (Investor's Business Daily)
04:25PM	Tempus: Q4 Earnings Snapshot (Associated Press Finance)
Feb-22-25 12:52AM	Tempus AI, Inc. (TEM) Secures $300 Million to Fuel Ambry Genetics Acquisition (Insider Monkey)
Feb-21-25 07:32AM	Why Tempus AI, Inc. (TEM) Crashed on Thursday (Insider Monkey) -11.25%
Feb-20-25 10:43AM	Why Tempus AI, Inc (TEM) is the Best Performing Healthcare Stock So Far in 2025 (Insider Monkey) -10.49%
Feb-19-25 03:58PM	Why Tempus AI (TEM) Crashed on Tuesday? (Insider Monkey)
10:40AM	Tempus AI Attracts Heavy Institutional Buying, Led by JPMorgan and ARK (GuruFocus.com)
08:30AM	Tempus to Present at TD Cowen's 45th Annual Health Care Conference (Business Wire)
Feb-18-25 04:30PM	Ares Management Upsizes Tempus Debt Facilities to $560 Million (Business Wire) -8.37%
08:30AM	Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference (Business Wire)
Feb-17-25 07:49AM	Why Tempus AI, Inc. (TEM) Soared Last Week (Insider Monkey)
Feb-14-25 01:17PM	Tempus AI, Inc. (TEM): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey) +6.79%
Feb-13-25 10:38PM	Why Tempus AI Inc. (TEM) Went Up on Thursday (Insider Monkey) +13.36%
02:22PM	Tempus AI Stock Soars to All-Time High (Investopedia)
12:25PM	Artera partners with Tempus to expand AI cancer test access (Medical Device Network)
09:40AM	William Blair Downgrades Tempus AI, Inc. (TEM) to Market Perform on Valuation Concerns (Insider Monkey)
08:30AM	Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma (Business Wire)
06:30AM	Think It's Too Late to Buy Tempus AI Stock? Here's the Biggest Reason Why There's Still Time. (Motley Fool)
Feb-12-25 12:19PM	Tempus AI, Inc. (TEM): Among the Large-Cap Stocks Insiders Are Selling Recently (Insider Monkey)
10:06AM	Tempus AI stock downgraded by William Blair after massive rally (Investing.com)
Feb-11-25 09:00AM	FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape (PR Newswire)
08:30AM	Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24 (Business Wire)
Feb-08-25 09:27AM	Tempus AI COO Ryan Fukushima sells 20,000 shares of stock (TipRanks)
Feb-06-25 02:30PM	Top ideas for non-chip AI investments in 2025 (Yahoo Finance Video) -6.06%
Feb-05-25 10:58PM	Why Tempus AI Inc. (TEM) Went Up on Wednesday (Insider Monkey) +11.85%
03:24PM	TD Cowen reinstates coverage on Tempus AI with 'buy' after Ambry deal (Investing.com)
01:39PM	Why Tempus AI (TEM) Is Jumping Today (Insider Monkey)
12:46PM	Jim Cramer Weighs In On Tempus AI, Inc. (TEM) Stock, Suggests Exploring Other Options (Insider Monkey)
09:31AM	AMD, Spotify downgraded: Wall Street's top analyst calls (The Fly)
07:59AM	Tempus AI (TEM) Acquires Ambry Genetics in $600M Precision Medicine Push (Insider Monkey)
Feb-03-25 10:14PM	Why Tempus AI Inc. (TEM) Soared on Monday (Insider Monkey) +7.23%
04:30PM	Tempus Completes Acquisition of Ambry Genetics (Business Wire)
12:22PM	Tempus AI Inc. (TEM): Among The Stocks That Started The Year On A High (Insider Monkey)
Jan-31-25 07:50AM	Why Tempus AI Inc. (TEM) Soared on Thursday (Insider Monkey)
Jan-30-25 04:17PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey) +12.65%
Jan-29-25 03:06PM	Why Do Cathie Wood and Nancy Pelosi Love This Small AI Stock? (Insider Monkey)
Jan-28-25 08:35AM	Tempus AI Chairman and CEO Eric Lefkofsky sells $62M of shares (TipRanks)
Jan-26-25 03:25AM	Why Tempus AI (TEM) Is Skyrocketing Now (Insider Monkey)
Jan-25-25 03:33PM	Cathie Wood makes bold $173 million bet on surging AI stock (TheStreet)
Jan-24-25 12:16PM	Tempus AI, Inc (TEM): Driving Personalized Care with AI Amid Loom Capitals Revised $52 Target (Insider Monkey) -6.27%
03:09AM	Why Tempus AI, Inc (TEM) Is Skyrocketing? (Insider Monkey)
Jan-23-25 11:03AM	Nancy Pelosi bets this unprofitable AI stock will surge (TheStreet) +8.70%
Jan-22-25 12:52PM	Tempus AI Jumps 64% in 5 Days--Pelosi & AI Hype Fuel Rally (GuruFocus.com) +5.90%
12:32PM	Why Tempus AI, Inc (TEM) Soared At The Start Of The Trading Week (Insider Monkey)
11:34AM	Tempus launches AI healthcare data consolidation app (Medical Device Network)
Jan-21-25 06:06PM	Here's Why This Medical AI Stock Soared 35% on Tuesday (Investopedia) +35.53%
05:42PM	Tempus AI, Inc. (TEM): Revolutionizing Patient Care with AI-Driven Health Concierge App, Olivia (Insider Monkey)
03:40PM	Why Tempus Ai Stock Is Skyrocketing Today (Motley Fool)
12:21PM	This Medical AI Stock Is Up 39% After Launch of Personal Health App (Barrons.com)
11:19AM	Apple downgrades, Netflix earnings, Tempus AI surges: Market Minute (Yahoo Finance Video)
08:30AM	Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients (Business Wire)
Jan-18-25 07:09PM	Tempus AI Inc (TEM): AI-Driven Healthcare Revolution (Insider Monkey)
Jan-16-25 08:45AM	How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection (GlobeNewswire)
02:44AM	Why Tempus AI (TEM) Is Among Wednesdays Top Gainers? (Insider Monkey)
Jan-15-25 08:30AM	Tempus Announces the National Launch of FDA-Approved xT CDx Test (Business Wire) +9.71%
Jan-14-25 03:51PM	Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine (Insider Monkey)
08:30AM	Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care (Business Wire)
05:46AM	Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off (GuruFocus.com)
12:57AM	Heres Why Tempus AI, Inc (TEM) Is Among Mondays Top Losers (Insider Monkey)
Jan-13-25 03:43PM	Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14% (GuruFocus.com) -13.81%

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '25	Sale	80.87	84,640	6,844,680	4,964,820	Feb 20 07:55 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 20 '25	Sale	74.09	69,231	5,129,325	4,895,589	Feb 20 07:55 PM
Fukushima Ryan	Chief Operating Officer	Feb 19 '25	Sale	81.87	2,868	234,814	944,460	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 20 '25	Sale	80.00	1,682	134,560	44,500	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '25	Sale	81.87	818	66,973	46,182	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 18 '25	Sale	82.36	61,582	5,072,077	153,080	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 19 '25	Sale	81.87	903	73,932	152,177	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 18 '25	Sale	82.32	64,381	5,299,820	172,857	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 19 '25	Sale	81.87	5,551	454,470	167,306	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 18 '25	Sale	82.33	31,780	2,616,308	189,320	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 19 '25	Sale	81.87	1,540	126,086	187,780	Feb 20 07:55 PM
RYAN BARTOLUCCI	Officer	Feb 20 '25	Proposed Sale	85.71	1,682	144,164		Feb 20 04:22 PM
JAMES ROGERS	Officer	Feb 18 '25	Proposed Sale	89.44	31,780	2,842,403		Feb 18 04:29 PM
ANDREW POLOVIN	Officer	Feb 18 '25	Proposed Sale	89.44	64,381	5,758,237		Feb 18 04:29 PM
ERIK PHELPS	Officer	Feb 18 '25	Proposed Sale	89.44	61,582	5,507,894		Feb 18 04:28 PM
Doudna Jennifer A	Director	Feb 14 '25	Sale	90.00	1,320	118,800	36,011	Feb 14 07:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 14 '25	Sale	85.78	80,003	6,862,467	5,049,460	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 13 '25	Sale	78.51	78,594	6,170,792	5,129,463	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 12 '25	Sale	70.02	84,948	5,948,059	5,208,057	Feb 14 04:33 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 13 '25	Sale	80.00	6,059	484,720	47,000	Feb 14 04:32 PM
JENNIFER A DOUDNA	Director	Feb 14 '25	Proposed Sale	83.75	11,253	942,439		Feb 14 04:23 PM
RYAN BARTOLUCCI	Officer	Feb 13 '25	Proposed Sale	73.88	6,059	447,639		Feb 13 04:31 PM
LEFKOFSKY ERIC P	Officer	Feb 12 '25	Proposed Sale	71.21	535,000	38,097,350		Feb 12 08:21 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 05 '25	Sale	67.57	5,934	400,960	214,662	Feb 07 05:38 PM
Polovin Andrew	EVP and General Counsel	Feb 05 '25	Sale	67.57	7,717	521,438	237,238	Feb 07 05:36 PM
Rogers James William	Chief Financial Officer	Feb 05 '25	Sale	67.57	8,712	588,670	221,100	Feb 07 05:35 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 06 '25	Sale	71.00	2,320	164,720	53,059	Feb 07 05:34 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 05 '25	Sale	67.57	1,858	125,545	55,379	Feb 07 05:34 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 06 '25	Sale	67.89	85,109	5,778,114	5,373,393	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 07 '25	Sale	67.53	80,388	5,428,398	5,293,005	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 05 '25	Sale	67.53	74,485	5,030,067	5,458,502	Feb 07 05:33 PM
Fukushima Ryan	Chief Operating Officer	Feb 04 '25	Sale	62.50	20,000	1,250,033	962,442	Feb 06 06:02 PM
Fukushima Ryan	Chief Operating Officer	Feb 05 '25	Sale	67.57	15,114	1,021,253	947,328	Feb 06 06:02 PM
RYAN BARTOLUCCI	Officer	Feb 06 '25	Proposed Sale	69.18	2,320	160,498		Feb 06 04:23 PM
Epstein David R	Director	Feb 03 '25	Sale	53.31	370	19,725	27,524	Feb 05 06:06 PM
Bartolucci Ryan M	Chief Accounting Officer	Jan 31 '25	Sale	60.00	13,770	826,200	57,237	Jan 31 09:26 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 31 '25	Sale	58.21	82,056	4,776,799	5,532,987	Jan 31 09:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 29 '25	Sale	53.86	79,118	4,261,125	5,692,669	Jan 31 09:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 30 '25	Sale	54.63	77,626	4,240,708	5,615,043	Jan 31 09:23 PM
RYAN BARTOLUCCI	Officer	Jan 31 '25	Proposed Sale	57.19	13,770	787,506		Jan 31 04:34 PM
LEFKOFSKY ERIC P	Officer	Jan 29 '25	Proposed Sale	51.02	520,000	26,530,400		Jan 29 08:44 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 23 '25	Sale	52.26	645,068	33,709,713	5,857,575	Jan 24 06:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 22 '25	Sale	49.84	476,209	23,733,244	6,502,643	Jan 24 06:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 24 '25	Sale	53.39	85,788	4,580,274	5,771,787	Jan 24 06:53 PM
LEFKOFSKY ERIC P	Officer	Jan 24 '25	Proposed Sale	54.84	85,788	4,704,614		Jan 24 06:50 PM
LEFKOFSKY ERIC P	Officer	Jan 23 '25	Proposed Sale	50.45	645,068	32,543,681		Jan 23 09:14 PM
LEFKOFSKY ERIC P	Officer	Jan 22 '25	Proposed Sale	47.64	476,209	22,686,597		Jan 22 09:29 PM
KEYWELL BRADLEY A	10% Owner	Jan 16 '25	Sale	34.84	510,364	17,781,775	15,483,365	Jan 17 06:15 PM
KEYWELL BRADLEY A	10% Owner	Jan 17 '25	Sale	35.10	265,000	9,302,159	15,218,365	Jan 17 06:15 PM
KEYWELL BRADLEY A	10% Owner	Jan 15 '25	Sale	35.45	170,720	6,052,768	15,993,729	Jan 17 06:15 PM
Fukushima Ryan	Chief Operating Officer	Jan 07 '25	Sale	39.61	20,000	792,192	982,442	Jan 08 04:23 PM
Fukushima Ryan	Chief Operating Officer	Jan 02 '25	Sale	34.66	1,265	43,845	1,002,442	Jan 03 04:52 PM
Fukushima Ryan	Officer	Jan 02 '25	Proposed Sale	33.76	1,265	42,706		Jan 02 07:19 PM
LEFKOFSKY ERIC P	CEO and Chairman	Dec 18 '24	Sale	37.54	187,655	7,045,334	9,557,283	Dec 20 09:00 PM
Rogers James William	Chief Financial Officer	Dec 16 '24	Sale	40.23	1,468	59,058	229,812	Dec 18 08:15 PM
Polovin Andrew	EVP and General Counsel	Dec 16 '24	Sale	40.23	1,130	45,460	244,955	Dec 18 08:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 16 '24	Sale	40.23	2,396	96,391	220,596	Dec 18 08:15 PM
Fukushima Ryan	Chief Operating Officer	Dec 16 '24	Sale	40.23	3,500	140,805	1,003,707	Dec 18 08:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Dec 16 '24	Sale	40.23	339	13,638	71,007	Dec 18 08:15 PM
LEFKOFSKY ERIC P	Officer	Dec 18 '24	Proposed Sale	38.95	400,000	15,580,000		Dec 18 05:21 PM
Polovin Andrew	EVP and General Counsel	Dec 11 '24	Sale	42.39	51,504	2,183,187	246,085	Dec 13 06:20 PM
Epstein David R	Director	Dec 11 '24	Sale	41.81	620	25,922	27,894	Dec 13 06:20 PM
Doudna Jennifer A	Director	Dec 11 '24	Sale	41.81	1,183	49,461	37,331	Dec 13 06:20 PM
Fukushima Ryan	Chief Operating Officer	Dec 11 '24	Sale	42.51	120,000	5,101,728	1,007,207	Dec 13 06:20 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 11 '24	Sale	42.48	82,109	3,488,346	233,256	Dec 13 06:20 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 12 '24	Sale	44.05	10,264	452,129	222,992	Dec 13 06:20 PM
Rogers James William	Chief Financial Officer	Dec 11 '24	Sale	42.30	83,025	3,511,957	231,280	Dec 13 06:20 PM
Leonsis Theodore	Director	Dec 11 '24	Option Exercise	0.85	210,000	179,382	210,000	Dec 13 06:20 PM

Dollar change -1.32
Percentage change -5.43	%

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT COWZ DVY

Index	S&P 500	P/E	16.32	EPS (ttm)	1.41	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	-8.89%
Market Cap	130.27B	Forward P/E	7.56	EPS next Y	3.04	Insider Trans	0.80%	Shs Float	5.67B	Perf Month	-12.46%
Income	8.02B	PEG	-	EPS next Q	0.71	Inst Own	67.13%	Short Float	1.75%	Perf Quarter	-13.68%
Sales	63.63B	P/S	2.05	EPS this Y	-4.87%	Inst Trans	-0.47%	Short Ratio	2.16	Perf Half Y	-19.71%
Book/sh	15.56	P/B	1.48	EPS next Y	2.73%	ROA	3.65%	Short Interest	99.17M	Perf Year	-15.61%
Cash/sh	3.61	P/C	6.36	EPS next 5Y	-0.96%	ROE	9.05%	52W Range	24.28 - 31.54	Perf YTD	-13.42%
Dividend Est.	1.70 (7.40%)	P/FCF	13.25	EPS past 5Y	-13.25%	ROI	5.42%	52W High	-27.17%	Beta	0.55
Dividend TTM	1.69 (7.36%)	Quick Ratio	0.92	Sales past 5Y	17.19%	Gross Margin	66.76%	52W Low	-5.40%	ATR (14)	0.60
Dividend Ex-Date	Jan 24, 2025	Current Ratio	1.17	EPS Y/Y TTM	272.80%	Oper. Margin	26.92%	RSI (14)	23.84	Volatility	3.17% 2.21%
Employees	81000	Debt/Eq	0.76	Sales Y/Y TTM	8.77%	Profit Margin	12.60%	Recom	2.29	Target Price	30.39
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	112.15%	Payout	119.94%	Rel Volume	1.74	Prev Close	24.29
Sales Surprise	2.38%	EPS Surprise	33.59%	Sales Q/Q	24.66%	Earnings	Feb 04 BMO	Avg Volume	45.95M	Price	22.97
SMA20	-9.86%	SMA50	-11.27%	SMA200	-16.35%	Trades		Volume	79,744,874	Change	-5.43%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Today 02:57PM	Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal (Seeking Alpha) -5.43%
01:01PM	1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC) (Seeking Alpha)
10:45AM	Pfizer Inc. (PFE) - Jim Cramer Declares: 'Dead Money - Close the Casket!' (Insider Monkey)
09:46AM	Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure (Zacks)
09:04AM	The Zacks Analyst Blog Highlights Johnson & Johnson and Pfizer (Zacks)
08:00AM	Loading…
08:00AM	Is Pfizer Stock A Sell As HHS Firings, Tariffs Cast A Pall On Pharma? (Investor's Business Daily)
Apr-03-25 06:03PM	GSK resolves patent lawsuit against Pfizer over RSV vaccines (Reuters)
04:08PM	Centessa Pharmaceuticals: Smooth Move To New Programs, But Questions Remain (Seeking Alpha)
09:59AM	JNJ vs. PFE: Which Drug Giant is a Better Buy Now? (Zacks)
09:27AM	Analyst Report: Pfizer Inc. (Morningstar Research)
09:00AM	GoodRx launches new e-commerce experience for prescriptions (Yahoo Finance)
08:30AM	Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna (Motley Fool)
08:05AM	A Historic Opportunity For Dividend Investors (Seeking Alpha)
05:47AM	Is Pfizer Stock a Buy? (Motley Fool)
04:40AM	2 Absurdly Cheap Stocks to Buy and Hold for Years (Motley Fool)
06:03PM	Loading…
Apr-02-25 06:03PM	Big Pharma Avoids Worst-Case Tariff Scenario (The Wall Street Journal)
06:00PM	My Top 10 High-Yield Dividend Stocks For April 2025: One Yields 8%-Plus (Seeking Alpha)
05:45PM	Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
12:43PM	Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump (TipRanks)
09:43AM	PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters (Zacks)
09:10AM	Proxy adviser ISS recommends against Pfizer executive pay proposal (Reuters)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
07:37AM	PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo (Zacks)
Apr-01-25 07:09PM	Why Major Pharmaceutical Stocks Tumbled on Tuesday (Motley Fool)
02:02PM	The FDA Is Finished as Firings Sweep Health Agencies. Drug Stocks Are Falling. (Barrons.com)
01:43PM	Corcept Therapeutics: New PROC SOC Treatment Option With Relacorilant Data Release (Seeking Alpha)
12:10PM	Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Is Pfizer Inc. (PFE) the Most Undervalued Healthcare Stock to Buy According to Analysts? (Insider Monkey)
08:15AM	2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating (MarketBeat)
07:31AM	Pfizers RSV vaccine wins expanded approval in EU, gaining edge over GSK (Pharmaceutical Technology)
05:50AM	Loading…
05:50AM	3 Ultra-High-Yield Dividend Stocks to Buy in April (Motley Fool)
04:00AM	Former Pfizer CSO Mikael Dolsten on writing his next chapter, embracing AI and asking the big questions (Pharma Voice)
03:00AM	European Commission Approves Pfizer's RSV Vaccine ABRYSVO to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease (Business Wire)
Mar-31-25 05:15PM	FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (Seeking Alpha)
03:39PM	Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity (Seeking Alpha)
11:52AM	Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' (Investopedia)
09:31AM	Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out (The Wall Street Journal)
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? (Zacks)
08:00AM	Pfizer: Looks Better Than Most, But I Can't Eat Relative Returns (Seeking Alpha)
Mar-30-25 08:47AM	Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows (Insider Monkey)
05:00AM	Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors (Seeking Alpha)
02:50AM	abrdn Healthcare Investors Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 04:49AM	Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks (Motley Fool)
Mar-28-25 03:59PM	TBLD: Profit From The Market's Shift Towards Europe With This CEF (Seeking Alpha)
11:06AM	Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (Rating Upgrade) (Seeking Alpha)
09:48AM	Arbutus Biopharma: A Wing And A Prayer (Seeking Alpha)
09:44AM	AbbVie Vs. Sanofi: Which Is The Better Investment Right Now (Seeking Alpha)
07:00AM	6 Ultra SWANs Potentially Set To Soar In 2025 (Seeking Alpha)
05:34AM	Genmabs Tivdak approved in Japan for advanced cervical cancer (Pharmaceutical Technology)
Mar-27-25 07:00PM	Pfizer: Value Play or Past Its Prime? (Motley Fool)
04:19PM	SCHD's Big Changes Impact The Dividend And Your Exposure (SeekingAlpha)
12:51PM	Pfizer Is Facing A First-Quarter Slowdown. Is Pfizer Stock Now A Sell? (Investor's Business Daily)
11:34AM	Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive (Zacks)
11:30AM	U.S. to end funding for child vaccines in developing countries, NY Times reports (TipRanks)
10:06AM	GSK accuses Pfizer of delaying Covid vaccine result until after US election (The Telegraph)
06:45AM	Why Pfizer Is My Largest Healthcare Position (Motley Fool)
05:06AM	Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks (StockStory)
Mar-26-25 06:43PM	U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine (The Wall Street Journal)
06:00PM	Strategically Building A $100,000 Dividend Portfolio For Attractive Income And Strong Risk-Adjusted Returns (SeekingAlpha)
05:45PM	Here's Why Pfizer (PFE) Fell More Than Broader Market (Zacks)
03:25PM	Pfizer Stock Slips After Report on Vaccine Timing Probe (The Wall Street Journal)
12:31PM	5 Reasons To Buy Regenxbio Right Now (SeekingAlpha)
09:01AM	ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program (PR Newswire)
Mar-25-25 05:12PM	Pfizer: Undervalued Defensive Play (GuruFocus.com)
04:05PM	Dexcom Appoints Jon Coleman as Chief Commercial Officer (Business Wire)
03:41PM	Pfizer Is Trading As If It's 2009 Again (SeekingAlpha)
06:47AM	5 Large Drug Stocks to Watch as Industry Recovers (Zacks)
02:20AM	Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Mar-24-25 04:19PM	Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds? (InsiderMonkey)
08:37AM	Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy? (Zacks)
06:29AM	J&J to Invest $55B in United States to Boost Manufacturing, R&D (Zacks)
Mar-23-25 08:42PM	China promotes business potential to Apple, Pfizer and other US companies (Reuters)
01:56PM	Is Pfizer Inc. (PFE) The Best Healthcare Dividend Stock to Invest in? (InsiderMonkey)
Mar-22-25 06:44AM	Buying These Dirt-Cheap Stocks Could Be a Brilliant Move (Motley Fool)
06:02AM	Pfizer: Bulls Need To Check Out Its Graham P/E (SeekingAlpha)
Mar-21-25 09:00PM	Looking For Yields: Pfizer, Spire, And TriCo Bancshares Are Consistent Moneymakers (Benzinga)
05:37PM	Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster (SeekingAlpha)
04:13PM	Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio (Investor's Business Daily)
02:04PM	Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug (Pharmaceutical Technology)
01:21PM	Alnylam Stock Jumps After the FDA Approves Its Heart Drug (The Wall Street Journal)
01:13PM	Upgrading Beam Therapeutics: Promising BEAM-302 Data Opens Door For Durable Gene Therapy (SeekingAlpha)
12:26PM	Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals (Zacks)
10:05AM	Alnylam Heart Drug Approval Sets Up Challenge With Pfizer (Bloomberg)
08:15AM	AstraZeneca deepens China investment; Editas loses CFO to Dyne (BioPharma Dive)
07:21AM	Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (SeekingAlpha)
Mar-20-25 06:13PM	Alnylam nabs key additional indication for Amvuttra (SeekingAlpha)
05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
03:00PM	GILD Stock Down on Report of Cut in HIV Prevention Spending (Zacks)
02:11PM	U.S. boosts bird flu response with another $100M in funds (SeekingAlpha)
12:30PM	Sanofi Inks $1.9B Deal With Dren Bio to Buy Autoimmune Disease Drug (Zacks)
11:15AM	Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers (SeekingAlpha)
10:00AM	Trump Trade: Reciprocal tariffs still to start on April 2 (TipRanks)
09:45AM	3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025 (Motley Fool)
09:40AM	My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys (SeekingAlpha)
09:00AM	2 High-Yield Dividend Stocks That Are Bargain Buys Right Now (Motley Fool)
08:45AM	Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B (Zacks)
08:18AM	Pfizer sells 7.3% stake in Haleon for $3.3bn (Pharmaceutical Technology)
07:30AM	More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield) (SeekingAlpha)
06:17AM	1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade (Motley Fool)
Mar-19-25 05:45PM	Pfizer (PFE) Stock Dips While Market Gains: Key Facts (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

TEM

Tempus AI Inc

PFE

Pfizer Inc

Upgrade your FINVIZ experience